Streetbeat News

Analyst Ratings

AAL

Analysts have given American Airlines Group (NASDAQ:AAL) a mixed rating over the last quarter, with 3 somewhat bullish, 7 indifferent, and no bearish ratings. The average 12-month price target for the company is $17.12, representing a 9.42% decrease from the previous average price target of $18.90.

Portfolio Pulse from Benzinga Insights

October 24, 2023 | 6:00 pm

AIRC

Apartment Income REIT (NYSE:AIRC) has received various analyst ratings in the last quarter, with 1 bullish, 2 somewhat bullish, and 1 indifferent. The company's average price target is $36.5, a decrease of 9.88% from the previous average of $40.5.

Portfolio Pulse from Benzinga Insights

October 24, 2023 | 6:00 pm

DAR

Raymond James analyst Justin Jenkins has maintained a 'Strong Buy' rating on Darling Ingredients (NYSE:DAR) but lowered the price target from $95 to $80.

Portfolio Pulse from Benzinga Newsdesk

October 24, 2023 | 6:00 pm

KMPR

Raymond James analyst C. Gregory Peters maintains a Strong Buy rating on Kemper (NYSE:KMPR) but has lowered the price target from $70 to $60.

Portfolio Pulse from Benzinga Newsdesk

October 24, 2023 | 5:58 pm

ESMT

EngageSmart Inc (NYSE:ESMT) has been downgraded by several analysts following its acquisition by Vista Equity Partners for $4.0 billion or $23 per share. The purchase price represents a premium of about 23% to the unaffected closing price of ESMT's shares on October 4, 2023. Analysts from Raymond James, KeyBanc Capital Markets, and Needham have downgraded the company's rating due to fair valuation concerns, despite projecting steady growth for the company.

Portfolio Pulse from Lekha Gupta

October 24, 2023 | 5:58 pm

AEMD

HC Wainwright & Co. analyst Vernon Bernardino maintains a 'Buy' rating on Aethlon Medical (NASDAQ:AEMD), but has lowered the price target from $90 to $23.

Portfolio Pulse from Benzinga Newsdesk

October 24, 2023 | 5:57 pm

DNLI

Cantor Fitzgerald analyst Charles Duncan has assumed coverage of Denali Therapeutics (NASDAQ:DNLI) with an Overweight rating, but has lowered the price target to $35.

Portfolio Pulse from Benzinga Newsdesk

October 24, 2023 | 5:55 pm

AXP

Piper Sandler analyst Kevin J. Barker upgraded American Express Co (NYSE:AXP) to Neutral from Underweight with a price target of $151, up from $150. Despite expecting revenue growth to slow and headwinds from weaker credit, Barker projects the company to deliver EPS growth of ~10% over the next two years. He also raised the FY24 revenue estimate to $65,475.8 million from $64,565 million earlier.

Portfolio Pulse from Lekha Gupta

October 24, 2023 | 5:55 pm

CRNX

Cantor Fitzgerald analyst Charles Duncan has assumed Crinetics Pharmaceuticals (NASDAQ:CRNX) with an Overweight rating, but has lowered the price target to $50.

Portfolio Pulse from Benzinga Newsdesk

October 24, 2023 | 5:53 pm

FDMT

Cantor Fitzgerald analyst Josh Schimmer has initiated coverage on 4D Molecular Therapeutics (NASDAQ:FDMT) with an Overweight rating and a price target of $32.

Portfolio Pulse from Benzinga Newsdesk

October 24, 2023 | 5:50 pm